More and more people being cared for on ventilators are conscious during the treatment, but what is it like to be fully conscious without being able to communicate with the world around you? A thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has lifted the lid on a world of panic, breathlessness and unheard pain…
According to a study published online in Thorax, asthma patients can improve their quality of life and ease persistent asthma symptoms during daytime by using a simple device called Protexo, which filters airborne asthma triggers from the air during sleep…
The US Food and Drug Administration (FDA) confirmed that the Decemember 31st 2011 ban on Chlorofluorocarbon (CFC) based asthma inhalers will go into force. The ban is part of the Montreal Protocol on substances that deplete the Ozone Layer., which dates back to international agreements made in the late 1980s…
An easy-to-use device developed by a local biomedical company is providing relief to Buffalo-area patients suffering from chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. The Lung Flute, one of Popular Science magazine’s best 100 innovations of 2009, is a hand-held device that employs sound-wave technology to break up mucus in the lungs…
Wheezy toddlers who have a sensitivity to house dust mites are more at risk of developing asthma by the age of 12, a University of Melbourne led study has shown. Children aged one two years with a family history of allergy, who had a positive skin prick test to house dust mites, had a higher risk of developing asthma later in life…
Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial-lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang…
People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests…
An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research by the University of East Anglia (UEA) and three US universities…
A mist inhaler used to deliver the drug tiotropium to patients with chronic obstructive pulmonary disease (COPD) may be linked to an increased risk of death, suggests a study published on bmj.com today. The findings add weight to recent safety concerns by regulatory agencies regarding the possibility of an increased mortality risk associated with this device…
Hospitals in Manchester and Glasgow in the UK have started treating asthma patients with a pioneering new non-drug treatment for asthma that uses radio waves to burn away muscle tissue blocking the airways in the lungs…